Interferon Needed For Cells to ‘Remember’ How to Defeat a Virus, UT Southwestern Researchers Report
News Dec 04, 2008
Scientists at UT Southwestern Medical Center have determined that the immune-system protein interferon plays a key role in “teaching” the immune system how to fight off repeated infections of the same virus.
The findings, available online and in the Dec. 15 issue of the Journal of Immunology, have potential application in the development of more effective vaccines and anti-viral therapies.
Typically, when a person is infected with a virus, the human body immediately generates a massive number of T cells – a type of immune cell – that kill off the infected cells. Once the infection has cleared, most of the T cells also die off, leaving behind a small pool of central memory cells that “remember” how to fight that particular type of virus if the person is infected again.
“In this study, we have uncovered interferon’s role and the key signaling protein, called IL-2, involved in generating memory T cells,” said Dr. David Farrar, assistant professor of immunology at UT Southwestern and senior author of the study.
“Knowing how T cells acquire this memory may help us design better strategies and vaccines to fight HIV and other infectious diseases. Further, our discovery was made using primary human CD4+ T cells, which underscores the relevance of our discovery to human immune responses.”
CD4+ T cells coordinate the actions of other cells at the site of infection.
When a virus or bacterium infects a human, the infected cells secrete several molecules, including a cytokine – or signaling protein – called interferon alpha. The action of interferon is what makes an infected person feel run down and tired. Although scientists knew that interferon alpha prevented a virus from multiplying and spreading, they didn’t know what role interferon played in the creation of memory cells.
In the current study, the UT Southwestern researchers show that both interferon alpha and another signaling protein called IL-12 are needed to induce the creation of memory cells. They found that interferon and IL-12 team up to promote the creation of a special set of cells that then secrete another signaling protein called IL-2. These IL-2-secreting cells are the ones that remain in the body and “remember” how to fight off the virus.
“Without the IL-2 signaling protein, you’ll generate a beautiful primary response against a virus, and you’ll eliminate the bug, but your body won’t remember how it defeated the virus,” Dr. Farrar said. “Without these memory cells, your body is defenseless against re-infections.”
Ann Davis, student research assistant in immunology and lead author of the study, said this suggests a new role for interferon: teacher.
“This is really the first demonstration of a role for interferon in teaching a T cell how to respond to viral infections,” she said.
Dr. Farrar added: “Up until now, interferon has always been appreciated for its role in inhibiting virus infections. But no one’s really paid attention to interferon and its role in regulating memory. That’s why we’re so excited about this result.”
The next step, Dr. Farrar said, is to complete the same study in mice. Early results show that mice with T cells that can’t respond to interferon are unable to protect themselves when a virus invades.
“Their immune systems have no idea how to fight the virus,” Dr. Farrar said.
Dr. Farrar said these early findings in mice may pave the way for designing more effective vaccines.
Other UT Southwestern researchers involved in the study were Hilario Ramos, student research assistant in immunology, and Dr. Laurie Davis, associate professor of internal medicine.
The National Institutes of Health supported the research.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
SCRaMbLE Speeds Up Yeast EvolutionNews
Scientists have created a new way of speeding up the genome evolution of baker’s yeast Saccharomyces cerevisiae. This is to develop a synthetic yeast strain that can be transformed on demand, making it industrial applications such as the mass production of advanced medicines to treat illnesses such as malaria and tuberculosis (TB).READ MORE
Artificial Cellular Compartments BuiltNews
How to install new capabilities in cells without interfering with their metabolic processes? A team from the Technical University of Munich (TUM) and the Helmholtz Zentrum München have altered mammalian cells in such a way that they formed artificial compartments in which sequestered reactions could take place, allowing the detection of cells deep in the tissue and also their manipulation with magnetic fields.READ MORE